Creo Medical Group PLC Total Assets
Creo Medical Group PLC total assets. Based on the latest financial reports, Creo Medical Group PLC (CREO) holds total assets worth GBX59.10 Million GBX (≈ $7.19K USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Creo Medical Group PLC for the company's overall valuation and market capitalisation.
Total Assets of Creo Medical Group PLC (2005–2025)
Total assets of Creo Medical Group PLC from 2005 to 2025. This chart illustrates how Creo Medical Group PLC's total assets have evolved over time, based on quarterly financial data. See today's stock price for Creo Medical Group PLC for real-time trading data and today's change.
Creo Medical Group PLC - Asset Composition Analysis
Creo Medical Group PLC Total Assets Breakdown (December 2025)
Creo Medical Group PLC total assets breakdown as of December 2025. Creo Medical Group PLC's total assets of GBX59.10 Million consist of 39.8% current assets and 60.2% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 21.0% |
| Accounts Receivable | GBX6.90 Million | 11.7% |
| Inventory | GBX2.50 Million | 4.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX1.30 Million | 2.2% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2005–2025)
This chart illustrates how Creo Medical Group PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CREO net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Creo Medical Group PLC's current assets represent 39.8% of total assets in 2025, an increase from 0.0% in 2005.
- Cash Position: Cash and equivalents constituted 21.0% of total assets in 2025, up from 0.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is accounts receivable at 11.7% of total assets.
Creo Medical Group PLC Competitors by Total Assets
Key competitors of Creo Medical Group PLC based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.30 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
|
China | CN¥7.51 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
|
TAIDOC TECHNOLOGY CORP
TW:4736
|
Taiwan | NT$13.07 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
Creo Medical Group PLC - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.22 | 2.75 | 2.77 |
| Quick Ratio | 2.88 | 2.62 | 2.46 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX16.20 Million | GBX35.90 Million | GBX38.67 Million |
Creo Medical Group PLC - Advanced Valuation Insights
This section examines the relationship between Creo Medical Group PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.40 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | -9.1% |
| Total Assets | GBX59.10 Million |
| Market Capitalization | $628.03K USD |
Valuation Analysis
Below Book Valuation: The market values Creo Medical Group PLC's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Creo Medical Group PLC's assets decreased by 9.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Creo Medical Group PLC (2005–2025)
The table below shows the annual total assets of Creo Medical Group PLC from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | GBX59.10 Million ≈ $7.19K |
-9.08% |
| 2024-12-31 | GBX65.00 Million ≈ $7.91K |
-15.14% |
| 2023-12-31 | GBX76.60 Million ≈ $9.32K |
+1.68% |
| 2022-12-31 | GBX75.34 Million ≈ $9.17K |
-25.12% |
| 2021-12-31 | GBX100.61 Million ≈ $12.24K |
+8.81% |
| 2020-12-31 | GBX92.46 Million ≈ $11.25K |
+4.76% |
| 2019-12-31 | GBX88.26 Million ≈ $10.74K |
+77.43% |
| 2018-12-31 | GBX49.75 Million ≈ $6.05K |
+417.17% |
| 2018-06-30 | GBX9.62 Million ≈ $1.17K |
-40.34% |
| 2017-06-30 | GBX16.12 Million ≈ $1.96K |
+566.83% |
| 2016-06-30 | GBX2.42 Million ≈ $294.20 |
-35.60% |
| 2016-02-29 | GBX3.75 Million ≈ $456.86 |
+259.53% |
| 2015-02-28 | GBX1.04 Million ≈ $127.07 |
-35.72% |
| 2014-02-28 | GBX1.62 Million ≈ $197.70 |
+850.20% |
| 2008-02-29 | GBX171.00K ≈ $20.81 |
-33.46% |
| 2007-02-28 | GBX257.00K ≈ $31.27 |
+59.63% |
| 2006-02-28 | GBX161.00K ≈ $19.59 |
+3120.00% |
| 2005-02-28 | GBX5.00K ≈ $0.61 |
-- |
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices del… Read more